Cylene Pharmaceuticals Receives $15,635,924 New Financing

Aug 12, 2011 • Deals
0 Flares 0 Flares ×
Company Name Cylene Pharmaceuticals
Information Release Date 8/11/2011
Transaction Type Debt
Amount $15,635,924
Round Undisclosed
Proceeds Purpose Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.

VentureDeal.com

TechZulu Inc.

Based in Los Angeles, California, TechZulu is an independent news organization delivering an insightful story of the technology industry by showcasing the very people creating it.

More Posts - Website - Twitter - Facebook - YouTube

0 Flares Facebook 0 Twitter 0 Google+ 0 LinkedIn 0 StumbleUpon 0 Reddit 0 Buffer 0 0 Flares ×
0 Flares Facebook 0 Twitter 0 Google+ 0 LinkedIn 0 StumbleUpon 0 Reddit 0 Buffer 0 0 Flares ×